The CDC advised clinicians to consider H5N1 avian flu in patients who have acute respiratory illness symptoms or conjunctivitis with relevant exposure, including to raw milk.

When the Centers for Disease Control and Prevention (CDC) released its 2022 STI surveillance report, it was far from a clean ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

With more than 82 million new gonorrhea infections occurring globally each year, gonorrhea is the second most common bacterial sexually transmitted infection (STI), affecting both men and women ...

If approved, zoliflodacin would be the first new antibiotic for treating gonorrhea in decades. The U.S. FDA has granted zoliflodacin a Qualified Infectious Disease Product (QIDP) designation.

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for zoliflodacin for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older.

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 ...

FDA is expected to notify Innoviva Specialty Therapeutics regarding its decision to conduct an Advisory Committee Meeting in the Day 74 letter If approved, zoliflodacin would be the first new ...

“Today’s acceptance of the zoliflodacin NDA marks significant progress toward delivering health care providers with a potential new oral treatment option for uncomplicated gonorrhea, including ...

With more than 82 million new gonorrhea infections occurring globally each year, gonorrhea is the second most common bacterial sexually transmitted infection (STI), affecting both men and women ...

It’s one step forward and two steps back for vaccine policy in the U.S. Plus, we discuss the fishy origins of sensitive teeth and megalodon diets.